Autor: |
Santos-Moreno P; Biomab - Center for Rheumatoid Arthritis, Calle 48 #13-86, Bogotá, Colombia. pedrosantosmoreno@hotmail.com., Caballero-Uribe CV; Servicio de reumatología, Fundación Hospital Universitario del Norte, Calle 30 al lado del parque Muvdi, Barranquilla, Colombia., Massardo ML; Servicio de reumatología, Universidad Católica de Chile, Av. Libertador General Bernardo O'Higgins #340, Santiago, Chile., Maldonado CG; Unidad de enfermedades autoinmunes, Hospital Monte Sinai, Miguel Cordero 6111 y Solano, Cuenca, Ecuador., Soriano ER; Servicio de reumatología, Servicio de Clínica Médica Hospital Italiano de Buenos Aires, Peron 4190, C1199ABB, CABA, Argentina., Pineda C; Investigación biomédica, Instituto Nacional de Rehabilitación, Calzada México-Xochimilco, 289, México City, Mexico., Cardiel M; Unidad de investigación, Hospital Cumbres de Guadalcazar, 58278, Morelia, Mexico., Benavides JA; Fundación CENCIS, Centro de Excelencia para la Calidad, Investigación y Desarrollo en Salud, AK 45 (Autopista Norte) No. 114 - 78 Oficina, 402, Bogota, Colombia., Beltrán PA; Coordinadora proyectos institucionales y salud pública, Fundación CENCIS, Centro de Excelencia para la Calidad, Investigación y Desarrollo en Salud, AK 45 (Autopista Norte) No. 114 - 78 Oficina, 402, Bogota, Colombia. |
Abstrakt: |
The implementation of excellence centers in specific diseases has been gaining recognition in the field of health; specifically in rheumatoid arthritis, where the prognosis of the disease is related to an early diagnosis and a timely intervention, it is necessary that the provision of health services is developed in an environment of quality, opportunity, and safety with the highest standards of care. A methodology that allows this implementation in such a way that is achievable by the most of the care centers is a priority to achieve a better attention to populations with this disease. In this paper, we propose a systematic and progressive methodology that will help all the institutions to develop successful models without faltering in the process. The expected impact on public health is defined by a better effective coverage of high-quality treatments, obtaining better health outcomes with safety and accessibility that reduces the budgetary impact for the health systems of our countries. |